A detailed history of Aigen Investment Management, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Aigen Investment Management, LP holds 6,132 shares of ABBV stock, worth $1.08 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
6,132
Holding current value
$1.08 Million
% of portfolio
0.25%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$163.84 - $199.33 $1 Million - $1.22 Million
6,132 New
6,132 $1.21 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $1.13 Million - $1.28 Million
7,055 Added 117.8%
13,044 $2.38 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $86,275 - $97,166
-627 Reduced 9.48%
5,989 $928,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $883,831 - $1.02 Million
6,616 New
6,616 $986,000
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $2.39 Million - $2.87 Million
-17,293 Reduced 93.1%
1,281 $207,000
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $2.49 Million - $2.86 Million
18,574 New
18,574 $2.49 Million
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $14 Million - $17.3 Million
-105,880 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $11.4 Million - $14.4 Million
105,880 New
105,880 $13.7 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $1.61 Million - $1.83 Million
-15,172 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $1.6 Million - $1.78 Million
15,172 New
15,172 $1.71 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $6.02 Million - $8.12 Million
-74,748 Closed
0 $0
Q3 2020

Nov 06, 2020

SELL
$85.91 - $100.83 $1.17 Million - $1.38 Million
-13,674 Reduced 15.46%
74,748 $6.55 Million
Q2 2020

Aug 10, 2020

BUY
$73.37 - $98.18 $2.71 Million - $3.62 Million
36,882 Added 71.56%
88,422 $8.68 Million
Q1 2020

May 08, 2020

BUY
$64.5 - $97.79 $3.32 Million - $5.04 Million
51,540 New
51,540 $3.93 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.